Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

A new compound was effective for imaging prostate cancer in rats.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Upadacitinib effectively treated alopecia areata when other treatments failed.

A group has developed therapies that show promise for treating cancer and various other conditions.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The article's correction clarifies scientific and methodological concerns about miR-200c-3p's role in alopecia areata.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Blocking certain immune signals can reduce skin damage from radiation therapy.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.